In CLL, as opposed to DLBCL, activation of BCR signaling does not involve activating BCR pathway mutations and can thus be viewed as antigen-dependent, resulting from BCR ligation via antigens that are present in the tumor microenvironment (43). Here, BCR is linked to diffuse large B-cell lymphoma.